Atara Biotherapeutics
ATRA
ATRA
145 hedge funds and large institutions have $1.34B invested in Atara Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
9% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 53
4% less funds holding
Funds holding: 151 → 145 (-6)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
Holders
145
Holding in Top 10
3
Calls
$426K
Puts
$436K
Top Buyers
| 1 | +$23.3M | |
| 2 | +$15M | |
| 3 | +$12.5M | |
| 4 |
BlackRock
New York
|
+$12M |
| 5 |
Goldman Sachs
New York
|
+$7.4M |
Top Sellers
| 1 | -$24M | |
| 2 | -$20.5M | |
| 3 | -$19.9M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$7.78M |
| 5 |
Two Sigma Investments
New York
|
-$7.34M |